Dr. Reddy’s Laboratories announces commercial launch of 2-DG

Dr. Reddy’s Laboratories on Monday announced the commercial launch of 2-deoxy-D-glucose(2-DG), a medicine which is developed by the Defence Research and Development Organisation(DRDO) for the treatment of Covid-19 patients. In the coming weeks, the Company will make the drug available in hospitals across metros and Tier 1 cities and subsequently expand the coverage to the rest of India. This 2-DG manufactured by Dr. Reddy has a purity of 99.5% and is being sold commercially under the brand name 2DGTM. The maximum retail price (MRP) of each sachet has been fixed at Rs. 990, with a subsidized rate offered to the government institutions. Watch!

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting